Enterin Inc.   Report issue

For profit Phase 1 Phase 2
Founded: Philadelphia PA United States (2016)

Organization Overview

First Clinical Trial
2017
NCT03047629
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Enterin Inc.

Active Ingredients

Drugs in Phase 2 Trials (1)

ent-01 (4 trials)

Drugs in Phase 1 Trials (1)

ent-03 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Constipation (Phase 2)

Dementia (Phase 1)

Parkinson Disease (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 5
  • # of Trial APIs: 2